Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

AstraZeneca recalls physician sample bottles of BRILINTA heart drug AstraZeneca said that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of BRILINTA (ticagrelor) 90mg tablets as a precautionary measure.
Drug Research > Drug Delivery > News
EC launches probe into Aspen's pricing practices for cancer drugs The European Commission has initiated a formal investigation to see whether Aspen Pharma had excessively priced five life-saving cancer medicines.
Drug Research > Drug Delivery > News Clinigen, Tesaro partner to supply ovarian cancer drug in Europe Clinigen Group’s Idis Managed Access division and Tesaro have partnered to launch a Managed Access Program (also known as an Early Access Program) in Europe for niraparib, the investigational PARP 1/2 inhibitor, for patients with recurrent ovarian cancer.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight